{"title":"Formulation and Evaluation of Colon Targeted Drug Delivery System","authors":"Suruse Pravin, Godbole Mangesh, Bhamre Kumudini, Shivhare Umesh","doi":"10.35652/igjps.2022.12011","DOIUrl":null,"url":null,"abstract":"Purpose:The objective of the present study was to develop colon targeted drug delivery system of Metronidazole using guar gum as the carrier.Methods:Matrix tablets containing various proportions of guar gum were prepared by direct compression technique. Rapidly disintegrating Metronidazole core tablets were prepared and compression coated with guar gum and 20% of microcrystalline cellulose. The tablets were evaluated for hardness, thickness, drug uniformity and subjected to in vitro drug release studies under conditions mimicking mouth to colon transit. Results and Conclusions: The FTIR study indicates no possible interaction between Metronidazole and carriers. The tablets were found within the permissible limits for various physiological parameters. In vitro drug release studies in pH 6.8 phosphate buffer solution containing rat cecal contents have demonstrated the susceptibility of guar gum to the colonic bacterial enzyme action with consequent drug release. The pretreatment of rats orally with 1 ml of 2% w/v aqueous dispersion of guar gum for 7 d induced enzyme specifically acting on guar gum thereby increasing drug release. Dissolution studies were performed in 0.1N HCl for 2 h, in pH 7.4 buffer for 3 h and pH 6.8 up to 24 h. The cumulative percentage of drug release of Metronidazole after 24 h in pH 6.8 phosphatebuffers was found to be 98.51±0.02, 86.69±0.02, 84.55±0.04, 39.31±0.02, 24.60±0.02, 18.85±0.02 for formulation F1, F2, F3, F4, F5 and F6. It can be concluded that formulation F1 is considered a potential formulation for targeting the drug to the colon. The results showed that guar gum protects the drug from being release completely in the physiological environment of stomach and small intestine.©2022iGlobal Research and PublishingFoundation. All rights reserved.","PeriodicalId":13366,"journal":{"name":"Indo Global Journal of Pharmaceutical Sciences","volume":"43 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indo Global Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35652/igjps.2022.12011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
结肠靶向给药系统的研制与评价
目的:建立以瓜尔胶为载体的甲硝唑结肠靶向给药系统。方法:采用直接加压法制备不同比例瓜尔胶基质片。制备快速崩解的甲硝唑芯片,并以瓜尔胶和20%微晶纤维素包被。对其硬度、厚度、均匀性进行了评价,并在模拟口腔到结肠转运的条件下进行了体外释药研究。结果与结论:FTIR研究表明,甲硝唑与携带者之间不存在相互作用。这些片剂在各种生理参数的允许范围内。在含有大鼠盲肠内容物的pH 6.8磷酸盐缓冲溶液中进行的体外药物释放研究表明,瓜尔胶对结肠细菌酶的作用具有敏感性,并随之释放药物。大鼠口服2% w/v瓜尔胶水分散体1ml预处理7 d,诱导酶特异性作用于瓜尔胶,从而增加药物释放。在0.1N HCl中溶出2 h,在pH 7.4的缓冲液中溶出3 h,在pH 6.8的缓冲液中溶出24 h,发现F1、F2、F3、F4、F5和F6配方中,甲硝唑在pH 6.8的磷酸盐缓冲液中24 h的累积释药率分别为98.51±0.02、86.69±0.02、84.55±0.04、39.31±0.02、24.60±0.02、18.85±0.02。可以得出结论,配方F1被认为是一种潜在的针对结肠的药物配方。结果表明,瓜尔胶对药物在胃和小肠的生理环境中完全释放有保护作用。©2022全球研究与出版基金会。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。